Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study
Attention and Grouping of Visual Information: What is Disturbed in Patients With Schizophrenia?
1 other identifier
observational
52
1 country
1
Brief Summary
The main objective of the study is to contribute to a better understanding of the physiopathology of schizophrenia, by studying causal relationships between cognitive deficits and the neurobiological basis for these deficits. Processing visual information involves both automatic grouping processes and control processes. Automatic grouping processes allow the building of a global configuration from local contour information. It is necessary in order to recognize objects. Control processes allow tending to and prioritizing information parts. The paradigm the investigators use allows to dissociate these processes, and is used in order to characterize the impairments observed in patients with schizophrenia. It is adapted to fMRI in order to explore the neurobiological basis of the deficits. The investigators will examine whether functional disconnectivity between activated areas subtend the impairments observed in patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2006
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2006
CompletedFirst Posted
Study publicly available on registry
July 11, 2006
CompletedStudy Start
First participant enrolled
September 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2009
CompletedJune 28, 2010
June 1, 2010
July 10, 2006
June 25, 2010
Conditions
Keywords
Study Arms (2)
Healthy volunteers
Healthy controls
Patients
Patients with schizophrenia
Interventions
Eligibility Criteria
Primary care clinic, residents of Strasbourg
You may qualify if:
- Patients with schizophrenia (DSM-IV criteria)
- Healthy controls matched with patients on age, sex and education level
- Ages 18 to 50
- Signed informed consent
- Right-handed
You may not qualify if:
- No severe somatic illness
- No invalidating sensory disease
- No drug abuse, as defined by DSM-IV criteria
- No general anaesthesia in the past 3 months
- No intake of drugs affecting the CNS, except for patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Strasbourg, Francelead
- Institut National de la Santé Et de la Recherche Médicale, Francecollaborator
- Centre National de la Recherche Scientifique, Francecollaborator
- Région Alsacecollaborator
- Faculté de Médecine de Strasbourgcollaborator
Study Sites (1)
Inserm U666 - Département de Psychiatrie, Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Giersch, MD
Institut National de la Santé Et de la Recherche Médicale, France
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 10, 2006
First Posted
July 11, 2006
Study Start
September 1, 2006
Study Completion
April 1, 2009
Last Updated
June 28, 2010
Record last verified: 2010-06